1,012 results on '"Budrukkar, A."'
Search Results
2. Intensity-Modulated Radiation Therapy Alone Versus Intensity-Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial
3. Development and Validation of Single-Optimization Knowledge-Based Volumetric Modulated Arc Therapy Model Plan in Nasopharyngeal Carcinomas
4. Long term results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.
5. A randomized trial to assess the effect of oral cryotherapy in the prevention of mucositis in patients with head and neck cancer receiving chemo-radiotherapy.
6. Function Preservation in Head and Neck Cancers
7. Challenges in the Sustainability of Brachytherapy Service in Contemporary Radiotherapy
8. Brachytherapy training in India: Results from the GEC-ESTRO-India survey
9. Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity
10. Image-guidance triggered adaptive radiation therapy in head and neck squamous cell carcinoma: single-institution experience and implications for clinical practice
11. Interdisciplinary and Regional Cooperation Towards Head and Neck Cancer Interventional Radiotherapy (Brachytherapy) Implementation in Southeast Asia
12. Post-cricoid and Upper Oesophagus Cancers Treated with Organ Preservation Using Intensity-modulated Image-guided Radiotherapy: a Phase II Prospective Study of Outcomes, Toxicity and Quality of Life
13. Concurrent chemoradiotherapy for locally advanced unresectable adenoid cystic carcinoma of head and neck: experience from a single institute
14. Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer With Brain Metastases: Real-World Experience
15. Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines
16. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial
17. Salvage surgery in head and neck cancer: Does it improve outcomes?
18. A comparison of long-term clinical outcomes of accelerated partial breast irradiation using interstitial brachytherapy as per GEC-ESTRO, ASTRO, updated ASTRO, and ABS guidelines
19. Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern era
20. Intensity Modulated Radiation Therapy Alone Vs Intensity Modulated Radiation Therapy and Brachytherapy for T1-T2N0M0 Oropharyngeal Cancers: Results from A Randomized Controlled Trial
21. Coverage with dosimetric concordance index (CDCI): a tool for evaluating dosimetric impact of inter-observer target variability in brachytherapy
22. Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern era
23. Survival outcomes with 12 weeks of adjuvant or neoadjuvant trastuzumab in breast cancer
24. Taxane-based Induction Chemotherapy Plus Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma: Prospective Results from a Non-endemic Cohort
25. Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation
26. Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched‐pair analysis
27. Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity
28. Head-and-neck cancer radiotherapy recommendations during the COVID-19 pandemic: Adaptations from the Indian subcontinent
29. Impact of inter-observer variations in target volume delineation on dose volume indices for accelerated partial breast irradiation with multi-catheter interstitial brachytherapy
30. Submandibular function recovery after IMRT in head and neck cancer: A prospective dose modelling study
31. Precision radiation oncology in head and neck cancer: beyond physical precision - a narrative review
32. Function Preservation with Brachytherapy: Reviving the Art
33. Psycho-oncology/Supportive Care in Head–Neck Cancers Patients Undergoing Radiation Therapy: A Randomized Controlled Trial
34. Development and validation of single-optimization knowledge-based volumetric modulated arc therapy model plan in nasopharyngeal carcinomas
35. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population
36. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial
37. Impact of adjuvant systemic chemotherapy on wound healing and cosmetic outcome in 224 women treated with accelerated partial breast irradiation using interstitial brachytherapy
38. Change of target volume and its dosimetric impact during the course of accelerated partial breast irradiation using intraoperative multicatheter interstitial brachytherapy after open cavity surgery
39. H&N and Skin (HNS) GEC-ESTRO Working Group critical review of recommendations regarding prescription depth, bolus thickness and maximum dose in skin superficial brachytherapy with flaps and customized moulds
40. SP-0196 What role for brachytherapy and SBRT?
41. OC-0760 A randomized trial of concurrent versus sequential Tamoxifen with radiotherapy for breast cancer
42. Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched‐pair analysis
43. Diagnostic Performance of Response Assessment FDG‐PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI‐RADS
44. Interobserver Variability in the Delineation of Gross Tumour Volume and Specified Organs-at-risk During IMRT for Head and Neck Cancers and the Impact of FDG-PET/CT on Such Variability at the Primary Site
45. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update – Improvement by cross sectional imaging based treatment planning and stepping source technology
46. Brachytherapy training in India: Results from the GEC-ESTRO-India survey
47. Challenges in the Sustainability of Brachytherapy Service in Contemporary Radiotherapy
48. Diagnostic Performance of Response Assessment FDG‐PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI‐RADS
49. Impact of in-homogenity corrected dose calculation of clinical Brachytherapy sites
50. Elective nodal dose of 60 Gy or 50 Gy in head and neck cancers: A matched pair analysis of outcomes and toxicity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.